[1]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2013/192556,2013,A2
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED;INTRA-CELLULARTHERAPIES,INC.-WO2014/205354,2014,A2
[1]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2013/192556,2013,A2
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED;INTRA-CELLULARTHERAPIES,INC.-WO2014/205354,2014,A2
[3]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2021/226407,2021,A1
[1]Li,Peng;Zheng,Hailin;Zhao,Jun;Zhang,Lei;Yao,Wei;Zhu,Hongwen;DavidBeard;Ida,Koh;Lane,Weston;Snell,Gyorgy;Sogabe,Satoshi;Heyser,CharlesJ.;Snyder,GretchenL.;Hendrick,JosephP.;Vanover,KimberlyE.;Davis,RobertE.;Wennogle,LawrenceP.[JournalofMedicinalChemistry,2016,vol.59,#3,p.1149-1164]
[2]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2021/226407,2021,A1Locationinpatent:Paragraph00036
[3]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2013/192556,2013,A2Locationinpatent:Paragraph0035-0040
[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED;INTRA-CELLULARTHERAPIES,INC.-WO2014/205354,2014,A2Locationinpatent:Page/Pagecolumn0094
[1]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2013/192556,2013,A2
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED;INTRA-CELLULARTHERAPIES,INC.-WO2014/205354,2014,A2
[3]Li,Peng;Zheng,Hailin;Zhao,Jun;Zhang,Lei;Yao,Wei;Zhu,Hongwen;DavidBeard;Ida,Koh;Lane,Weston;Snell,Gyorgy;Sogabe,Satoshi;Heyser,CharlesJ.;Snyder,GretchenL.;Hendrick,JosephP.;Vanover,KimberlyE.;Davis,RobertE.;Wennogle,LawrenceP.[JournalofMedicinalChemistry,2016,vol.59,#3,p.1149-1164]
[4]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2021/226407,2021,A1
[1]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2013/192556,2013,A2
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED;INTRA-CELLULARTHERAPIES,INC.-WO2014/205354,2014,A2
[3]Li,Peng;Zheng,Hailin;Zhao,Jun;Zhang,Lei;Yao,Wei;Zhu,Hongwen;DavidBeard;Ida,Koh;Lane,Weston;Snell,Gyorgy;Sogabe,Satoshi;Heyser,CharlesJ.;Snyder,GretchenL.;Hendrick,JosephP.;Vanover,KimberlyE.;Davis,RobertE.;Wennogle,LawrenceP.[JournalofMedicinalChemistry,2016,vol.59,#3,p.1149-1164]
[4]CurrentPatentAssignee:INTRA-CELLULARTHERAPIES,INC.-WO2021/226407,2021,A1
Title: Li P, et al. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. J Med Chem. 2016;59(3):1149-1164.
Title: Snyder GL, et al. Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats. Psychopharmacology (Berl). 2016;233(17):3113-3124.